Colossal
PrivateLast Round
Series C
Extension
Sep 17, 2025
Est. Valuation
$10.32B
Total Funding Raised
$545M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Colossal Laboratories & Biosciences is a bioscience and genetic engineering company dedicated to developing innovative technologies aimed at advancing genomics, including species de-extinction and ecosystem restoration through the application of CRISPR technology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, ML Platforms
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts, Data as a Service
AI Layer
Application
Keywords
Price History
Caplight MarketPrice™ estimate for Colossal, published with a 90-day delay.
Caplight MarketPrice™
$8.79
per share, as of April 2026
-59.3%
1-year change
Caplight MarketPrice™ is an estimate of private secondary market pricing, shown here on a delayed basis for illustrative purposes only. It may be incomplete, is subject to change, and may not be relied upon for any purpose or considered investment advice.
Colossal Comparables
Compare Colossal with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Revive & Restore | 71% | |
| Ginkgo Bioworks | 61% | |
| Los Angeles Project | 56% | |
Colossal Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C Extension | Sep 17, 2025 | ||||
| Series C | Jan 15, 2025 | ||||
| Series B | Jan 31, 2023 | ||||
| Grant | Oct 5, 2022 | ||||
| Series A | Mar 9, 2022 | ||||
Seed | Sep 13, 2021 |
Key People
Founding team and executive leadership
Colossal Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| TWG Global | Series C |
| S32 | Series A |
| Breyer Capital | Series C, Series B, Series A, Seed |
| Global Space Ventures | Seed |
| Untamed Planet | Series A |
| US Innovative Technology Fund | Series B |
| Builders VC | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 30, 2026
Partnered with Endangered Wildlife Trust for bluebuck rewilding.
- Apr 21, 2026
Won a gold Edison Award for mammalian cloning method.
Colossal Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Appears On
Curated lists and screens where this company is featured.
Frequently Asked Questions
Common questions about Colossal's valuation, stock price, and market status.